We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WHF:NASDAQWhiteHorse Finance, Inc. Analysis

Data as of 2026-05-28 - not real-time

$6.80

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

WhiteHorse Finance is trading near its short‑term support with the 20‑day moving average just under the 50‑day average, suggesting modest bearish pressure while the RSI signals an oversold condition. Technical momentum is mixed – the MACD histogram is negative and the MACD line sits below its signal, yet volume is trending upward, indicating some buying interest. Fundamentally, the company faces a strained balance sheet with a very high debt‑to‑equity ratio, negative free cash flow, and a payout ratio far above sustainable levels, which has led to a recent earnings miss and net losses on the latest quarter. Despite these challenges, the discounted cash flow model points to a valuation many times current price, and the dividend yield remains exceptionally high, though its durability is questionable. The stock’s beta is low, suggesting limited market‑wide volatility, but its own price volatility is elevated, reflecting uncertainty around cash flow and earnings consistency. Overall, the blend of technical oversold signals, strong upside potential from valuation, and significant financial headwinds creates a nuanced outlook.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Oversold RSI suggests potential bounce
  • Negative MACD indicates continued downside pressure
  • Increasing volume provides some support for stability

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF valuation shows substantial upside
  • Support level near current price offers downside cushion
  • Improved earnings outlook could reduce loss momentum

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • High debt and unsustainable dividend raise structural concerns
  • Low beta mitigates broader market risk
  • Potential for value realization if cash flow improves

Key Metrics & Analysis

Financial Health

Revenue Growth-15.60%
Profit Margin13.46%
P/E Ratio16.6
ROE3.53%
ROA4.62%
Debt/Equity129.48
P/B Ratio0.6
Op. Cash Flow$112.5M
Free Cash Flow$-22383000
Industry P/E16.6

Technical Analysis

TrendNeutral
RSI35.6
Support$6.36
Resistance$7.69
MA 20$7.29
MA 50$7.38
MA 200$7.32
MACDBearish
VolumeIncreasing
Fear & Greed Index92.34

Valuation

Fair Value$33.44
Target Price$7.67
Upside/Downside12.75%
GradeUndervalued
TypeValue
Dividend Yield15.11%

Risk Assessment

Beta0.44
Volatility35.37%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.